QT
NVAX icon

Quantamental Technologies’s Novavax NVAX Stock Holding History

Quantamental Technologies’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$96.3K Buy
+13,308
New +$106K 0.09% 256
2022
Q3 		– Sell
-9,074
Closed -$467K – 620
2022
Q2 		$467K Buy
+9,074
New +$470K 0.21% 177
2019
Q3 		– Sell
-239
Closed -$1K – 1725
2019
Q2 		$1K Buy
+239
New +$1.88K ﹤0.01% 1411

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Quantamental Technologies's NVAX Position: Q3 2023 in Review

Quantamental Technologies opened a new position in Novavax (NVAX) in Q3 2023: 13,308 shares worth $96.3K. The stake represents 0.09% of the portfolio and ranks #256 among its holdings. This is a return to the name: Quantamental Technologies previously reported a position in NVAX as recently as Q2 2022.

Quantamental Technologies first reported a position in NVAX in Q2 2019 and has held it in 3 quarters since. The position peaked at $467K in Q2 2022. 225 funds tracked by Wall St. Rank hold NVAX as of Q3 2023.

  • Quantamental Technologies held 13,308 shares of Novavax worth $96.3K as of Q3 2023.
  • Novavax was a new Quantamental Technologies position in Q3 2023.
  • Novavax made up 0.09% of Quantamental Technologies's portfolio in Q3 2023, its #256 holding.
  • Quantamental Technologies first reported a position in Novavax in Q2 2019 and has held it in 3 quarters since.
  • Quantamental Technologies's Novavax position peaked at $467K in Q2 2022.
  • 225 funds tracked by Wall St. Rank held Novavax as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.